Id: | acc2146 |
Group: | 2sens |
Protein: | p53 |
Gene Symbol: | TP53 |
Protein Id: | P04637 |
Protein Name: | P53_HUMAN |
PTM: | phosphorylation |
Site: | Ser15 |
Site Sequence: | SDPSVEPPLSQETFSDLWKLL |
Disease Category: | Cancer |
Disease: | Colorectal Cancer |
Disease Subtype: | |
Disease Cellline: | HCT116 |
Disease Info: | |
Drug: | NO + ionizing radiation |
Drug Info: | NO: - Ionizing radiation refers to radiation composed of particles or electromagnetic waves with sufficient energy to ionize atoms or molecules by detaching electrons from them. |
Effect: | enhance |
Effect Info: | NO and ionizing radiation significantly enhance p53-dependent apoptosis by increasing the phosphorylation of p53 at serine 15. |
Note: | Non-conventional drugs |
Score: | 4.5 |
Pubmed(PMID): | 15520210 |
Sentence Index: | 15520210_5-6 |
Sentence: | We report that NO and ionizing radiation synergistically activate p53 in colorectal cancers grown in athymic mice by augmenting phosphorylation of p53 at serine 15. The effect of NO and ionizing radiation on tumor cell apoptosis and tumor radioresponsiveness is significantly reduced in p53 knockout isogenic cancer cell lines. |
Sequence & Structure:
MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPAAPAPAPSWPLSSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNTSSSPQPKKKPLDGEYFTLQIRGRERFEMFRELNEALELKDAQAGKEPGGSRAHSSHLKSKKGQSTSRHKKLMFKTEGPDSD
Select PDB:
Target | Drug name | MOA | Phase | Status | Disease | Source |
---|---|---|---|---|---|---|
TP53 | EPRENETAPOPT | Cellular tumor antigen p53 stabiliser | 3 | Completed | myelodysplastic syndrome | ClinicalTrials |
TP53 | IDASANUTLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 3 | Terminated | acute myeloid leukemia | ClinicalTrials |
TP53 | CENERSEN SODIUM | p53 mRNA antisense inhibitor | 2 | Terminated | chronic lymphocytic leukemia | ClinicalTrials |
TP53 | CENERSEN | p53 mRNA antisense inhibitor | 2 | Completed | acute myeloid leukemia | ClinicalTrials |
TP53 | CENERSEN | p53 mRNA antisense inhibitor | 2 | Withdrawn | acute myeloid leukemia | ClinicalTrials |
TP53 | NAVTEMADLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 2 | Recruiting | essential thrombocythemia | ClinicalTrials |
TP53 | SIREMADLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 2 | Recruiting | neoplasm | ClinicalTrials |
TP53 | IDASANUTLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 2 | Recruiting | neoplasm | ClinicalTrials |
TP53 | NAVTEMADLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 2 | Terminated | small cell lung carcinoma | ClinicalTrials |
TP53 | NAVTEMADLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 2 | Active, not recruiting | polycythemia vera | ClinicalTrials |
TP53 | NAVTEMADLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 2 | Recruiting | polycythemia vera | ClinicalTrials |
TP53 | NAVTEMADLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 2 | Recruiting | primary myelofibrosis | ClinicalTrials |
TP53 | IDASANUTLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 2 | Terminated | polycythemia vera | ClinicalTrials |
TP53 | CONTUSUGENE LADENOVEC | Cellular tumor antigen p53 exogenous gene | 2 | Unknown status | non-small cell lung carcinoma | ClinicalTrials |
TP53 | APG115 | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 2 | Recruiting | lymphoid leukemia | ClinicalTrials |
TP53 | CONTUSUGENE LADENOVEC | Cellular tumor antigen p53 exogenous gene | 2 | Terminated | head and neck malignant neoplasia | ClinicalTrials |
TP53 | CONTUSUGENE LADENOVEC | Cellular tumor antigen p53 exogenous gene | 2 | Unknown status | head and neck malignant neoplasia | ClinicalTrials ClinicalTrials |
TP53 | EPRENETAPOPT | Cellular tumor antigen p53 stabiliser | 2 | Withdrawn | Mantle cell lymphoma | ClinicalTrials |
TP53 | TEPRASIRAN | p53 mRNA RNAi inhibitor | 2 | Completed | Acute kidney injury | ClinicalTrials |
TP53 | EPRENETAPOPT | Cellular tumor antigen p53 stabiliser | 2 | Completed | ovarian cancer | ClinicalTrials |
TP53 | CONTUSUGENE LADENOVEC | Cellular tumor antigen p53 exogenous gene | 2 | Completed | breast cancer | ClinicalTrials |
TP53 | NAVTEMADLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 2 | Recruiting | endometrial cancer | ClinicalTrials |
TP53 | CENERSEN | p53 mRNA antisense inhibitor | 1 | Terminated | myelodysplastic syndrome | ClinicalTrials |
TP53 | NAVTEMADLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 1 | Active, not recruiting | acute myeloid leukemia | ClinicalTrials ClinicalTrials |
TP53 | NAVTEMADLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 1 | Completed | acute myeloid leukemia | ClinicalTrials |
Note: Only show clinically investigational or approved drugs with protein targets.
Protein Tractability:
source: Open TargetsPTM Intensity:
source: CPTACNo intensity data of this site,
show all other sites!
TP53-Ser314 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.707 |
HGSC | |
ccRCC | |
GBM | |
HNSC | -0.707 |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53-Ser315 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -1.105 |
HGSC | 0.842 |
ccRCC | 0.263 |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53-Thr150 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | -0.707 |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 0.707 |
TP53BP1-Ser101 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.422 |
HGSC | -1.142 |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 0.72 |
TP53BP1-Ser1024 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | 0.707 |
GBM | |
HNSC | |
LUAD | -0.707 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser1030 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -1.646 |
HGSC | |
ccRCC | 0.325 |
GBM | 1.443 |
HNSC | -0.173 |
LUAD | 0.213 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | -0.162 |
TP53BP1-Ser1033 | |
---|---|
Cancer | Intensity |
BRCA | 1.211 |
COAD | -0.937 |
HGSC | 2.312 |
ccRCC | -0.583 |
GBM | -0.187 |
HNSC | -0.362 |
LUAD | -0.923 |
LUSC | -0.762 |
non_ccRCC | 0.539 |
PDAC | -0.285 |
UCEC | -0.023 |
TP53BP1-Ser1039 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | 0.707 |
non_ccRCC | |
PDAC | |
UCEC | -0.707 |
TP53BP1-Ser1072 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.707 |
HGSC | 1.378 |
ccRCC | 0.381 |
GBM | 0.572 |
HNSC | -1.199 |
LUAD | -1.107 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 0.682 |
TP53BP1-Ser1073 | |
---|---|
Cancer | Intensity |
BRCA | 0.669 |
COAD | -1.359 |
HGSC | 1.711 |
ccRCC | 0.013 |
GBM | -1.1 |
HNSC | -0.352 |
LUAD | -0.325 |
LUSC | -0.93 |
non_ccRCC | 1.416 |
PDAC | 0.594 |
UCEC | -0.338 |
TP53BP1-Ser108 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | -1.494 |
ccRCC | 0.385 |
GBM | |
HNSC | 0.592 |
LUAD | 0.518 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser1091 | |
---|---|
Cancer | Intensity |
BRCA | -0.162 |
COAD | |
HGSC | |
ccRCC | 0.068 |
GBM | |
HNSC | -0.502 |
LUAD | -1.047 |
LUSC | |
non_ccRCC | 1.887 |
PDAC | |
UCEC | -0.245 |
TP53BP1-Ser1099 | |
---|---|
Cancer | Intensity |
BRCA | -0.026 |
COAD | -0.791 |
HGSC | 2.796 |
ccRCC | -0.009 |
GBM | -0.536 |
HNSC | -0.528 |
LUAD | -0.656 |
LUSC | -0.569 |
non_ccRCC | 0.469 |
PDAC | -0.136 |
UCEC | -0.016 |
TP53BP1-Ser110 | |
---|---|
Cancer | Intensity |
BRCA | 1.172 |
COAD | |
HGSC | -1.547 |
ccRCC | |
GBM | |
HNSC | |
LUAD | -0.219 |
LUSC | 0.235 |
non_ccRCC | |
PDAC | |
UCEC | 0.359 |
TP53BP1-Ser1106 | |
---|---|
Cancer | Intensity |
BRCA | -0.4 |
COAD | -1.116 |
HGSC | -0.312 |
ccRCC | 0.547 |
GBM | -0.568 |
HNSC | -0.441 |
LUAD | -0.968 |
LUSC | -0.471 |
non_ccRCC | 2.364 |
PDAC | 0.704 |
UCEC | 0.661 |
TP53BP1-Ser1109 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.039 |
HGSC | -2.593 |
ccRCC | 0.274 |
GBM | 0.059 |
HNSC | 0.319 |
LUAD | |
LUSC | 0.217 |
non_ccRCC | 0.798 |
PDAC | 0.535 |
UCEC | 0.352 |
TP53BP1-Ser1118 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.141 |
HGSC | -1.543 |
ccRCC | -1.102 |
GBM | 0.247 |
HNSC | 1.264 |
LUAD | -0.614 |
LUSC | 0.464 |
non_ccRCC | -0.502 |
PDAC | 1.68 |
UCEC | 0.245 |
TP53BP1-Ser1119 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.086 |
HGSC | -2.266 |
ccRCC | 0.103 |
GBM | 0.966 |
HNSC | 0.693 |
LUAD | 0.411 |
LUSC | |
non_ccRCC | |
PDAC | -0.265 |
UCEC | 0.442 |
TP53BP1-Ser1221 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.707 |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -0.707 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser1224 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.707 |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -0.707 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser124 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.494 |
HGSC | -1.151 |
ccRCC | |
GBM | |
HNSC | |
LUAD | 0.657 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser1293 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -1.016 |
HGSC | 1.342 |
ccRCC | |
GBM | 0.076 |
HNSC | -0.402 |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser1295 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.707 |
HNSC | -0.707 |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser1300 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.707 |
HNSC | -0.707 |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser1301 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.707 |
HNSC | -0.707 |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser132 | |
---|---|
Cancer | Intensity |
BRCA | 0.744 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -1.235 |
LUSC | 0.878 |
non_ccRCC | |
PDAC | |
UCEC | -0.387 |
TP53BP1-Ser1322 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.707 |
HGSC | 0.707 |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser1325 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.707 |
HGSC | 0.707 |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser1327 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.707 |
HGSC | 0.707 |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser1347 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | 0.707 |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | -0.707 |
TP53BP1-Ser1367 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.307 |
HGSC | 1.914 |
ccRCC | -0.145 |
GBM | |
HNSC | -0.147 |
LUAD | -1.067 |
LUSC | |
non_ccRCC | |
PDAC | -0.247 |
UCEC |
TP53BP1-Ser1431 | |
---|---|
Cancer | Intensity |
BRCA | 0.246 |
COAD | 0.043 |
HGSC | -2.497 |
ccRCC | 0.213 |
GBM | 0.159 |
HNSC | -0.014 |
LUAD | -0.134 |
LUSC | -0.797 |
non_ccRCC | 1.417 |
PDAC | 0.55 |
UCEC | 0.816 |
TP53BP1-Ser1435 | |
---|---|
Cancer | Intensity |
BRCA | -0.113 |
COAD | -0.034 |
HGSC | -2.759 |
ccRCC | 0.293 |
GBM | 0.398 |
HNSC | -0.001 |
LUAD | -0.361 |
LUSC | 0.187 |
non_ccRCC | 0.999 |
PDAC | 0.705 |
UCEC | 0.686 |
TP53BP1-Ser1467 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.052 |
HGSC | -1.961 |
ccRCC | 0.335 |
GBM | |
HNSC | 0.235 |
LUAD | 0.458 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 0.88 |
TP53BP1-Ser1479 | |
---|---|
Cancer | Intensity |
BRCA | 1.04 |
COAD | |
HGSC | |
ccRCC | -0.431 |
GBM | |
HNSC | -0.965 |
LUAD | -0.754 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 1.11 |
TP53BP1-Ser1485 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | -1.145 |
ccRCC | |
GBM | |
HNSC | 0.704 |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 0.441 |
TP53BP1-Ser1486 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.176 |
HGSC | -1.675 |
ccRCC | |
GBM | 0.676 |
HNSC | 0.499 |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 0.676 |
TP53BP1-Ser1553 | |
---|---|
Cancer | Intensity |
BRCA | -0.399 |
COAD | -0.09 |
HGSC | -1.597 |
ccRCC | -0.186 |
GBM | 2.062 |
HNSC | -0.731 |
LUAD | 0.544 |
LUSC | |
non_ccRCC | -0.011 |
PDAC | |
UCEC | 0.406 |
TP53BP1-Ser1570 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | 0.707 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | -0.707 |
TP53BP1-Ser1623 | |
---|---|
Cancer | Intensity |
BRCA | 0.109 |
COAD | 0.706 |
HGSC | -0.313 |
ccRCC | 0.633 |
GBM | -0.649 |
HNSC | -0.116 |
LUAD | -0.594 |
LUSC | -2.106 |
non_ccRCC | |
PDAC | 1.333 |
UCEC | 0.996 |
TP53BP1-Ser1636 | |
---|---|
Cancer | Intensity |
BRCA | 2.069 |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.803 |
HNSC | 0.499 |
LUAD | -0.343 |
LUSC | -0.484 |
non_ccRCC | |
PDAC | -0.596 |
UCEC | -0.341 |
TP53BP1-Ser1639 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.707 |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | -0.707 |
TP53BP1-Ser1640 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.48 |
HGSC | -2.197 |
ccRCC | |
GBM | 0.518 |
HNSC | -0.103 |
LUAD | |
LUSC | 0.197 |
non_ccRCC | 0.631 |
PDAC | 0.473 |
UCEC |
TP53BP1-Ser1647 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.281 |
HGSC | 1.11 |
ccRCC | -0.829 |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser1648 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | 1.462 |
ccRCC | -0.179 |
GBM | -0.704 |
HNSC | -0.579 |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser1649 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.509 |
HGSC | 1.152 |
ccRCC | |
GBM | -0.643 |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser1650 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.045 |
HGSC | 1.661 |
ccRCC | |
GBM | -0.557 |
HNSC | -0.1 |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | -0.959 |
TP53BP1-Ser1670 | |
---|---|
Cancer | Intensity |
BRCA | -1.256 |
COAD | |
HGSC | |
ccRCC | |
GBM | 1.05 |
HNSC | 0.489 |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | -0.283 |
TP53BP1-Ser1678 | |
---|---|
Cancer | Intensity |
BRCA | -0.443 |
COAD | |
HGSC | |
ccRCC | 0.603 |
GBM | |
HNSC | 0.93 |
LUAD | -1.54 |
LUSC | 0.45 |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser1683 | |
---|---|
Cancer | Intensity |
BRCA | -0.772 |
COAD | 0.322 |
HGSC | 1.65 |
ccRCC | -0.051 |
GBM | -0.095 |
HNSC | -0.488 |
LUAD | -1.952 |
LUSC | -0.351 |
non_ccRCC | 1.276 |
PDAC | -0.344 |
UCEC | 0.805 |
TP53BP1-Ser1691 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | -0.707 |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 0.707 |
TP53BP1-Ser1706 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.707 |
HGSC | -0.707 |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser1710 | |
---|---|
Cancer | Intensity |
BRCA | -1.394 |
COAD | 0.841 |
HGSC | -0.038 |
ccRCC | |
GBM | |
HNSC | 0.59 |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser1763 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.438 |
HGSC | -0.706 |
ccRCC | |
GBM | |
HNSC | 1.144 |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser1764 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.707 |
HGSC | -0.707 |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser1976 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.707 |
HGSC | 0.707 |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser207 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | -1.152 |
GBM | |
HNSC | 0.647 |
LUAD | 0.505 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser213 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | -1.494 |
ccRCC | |
GBM | 0.482 |
HNSC | |
LUAD | |
LUSC | 0.615 |
non_ccRCC | |
PDAC | |
UCEC | 0.398 |
TP53BP1-Ser227 | |
---|---|
Cancer | Intensity |
BRCA | -0.559 |
COAD | 1.032 |
HGSC | -2.558 |
ccRCC | 0.347 |
GBM | 0.449 |
HNSC | -0.102 |
LUAD | -0.028 |
LUSC | 0.4 |
non_ccRCC | -0.468 |
PDAC | 1.106 |
UCEC | 0.381 |
TP53BP1-Ser264 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | 0.99 |
ccRCC | -0.182 |
GBM | |
HNSC | -0.921 |
LUAD | -0.976 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 1.09 |
TP53BP1-Ser270 | |
---|---|
Cancer | Intensity |
BRCA | -1.282 |
COAD | -0.547 |
HGSC | 0.337 |
ccRCC | 0.598 |
GBM | -1.076 |
HNSC | -0.407 |
LUAD | -0.065 |
LUSC | 0.122 |
non_ccRCC | 2.428 |
PDAC | -0.468 |
UCEC | 0.359 |
TP53BP1-Ser285 | |
---|---|
Cancer | Intensity |
BRCA | 1.685 |
COAD | |
HGSC | |
ccRCC | -0.745 |
GBM | 1.526 |
HNSC | -0.932 |
LUAD | -0.956 |
LUSC | -0.513 |
non_ccRCC | 0.35 |
PDAC | -0.309 |
UCEC | -0.105 |
TP53BP1-Ser292 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -1.068 |
HGSC | |
ccRCC | 0.155 |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | 0.914 |
UCEC |
TP53BP1-Ser299 | |
---|---|
Cancer | Intensity |
BRCA | 0.87 |
COAD | -0.078 |
HGSC | -2.675 |
ccRCC | -0.093 |
GBM | -0.102 |
HNSC | 0.366 |
LUAD | 0.294 |
LUSC | |
non_ccRCC | 0.809 |
PDAC | 0.331 |
UCEC | 0.278 |
TP53BP1-Ser306 | |
---|---|
Cancer | Intensity |
BRCA | 0.988 |
COAD | |
HGSC | -2.119 |
ccRCC | -0.082 |
GBM | 0.471 |
HNSC | 0.168 |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | 0.523 |
UCEC | 0.051 |
TP53BP1-Ser315 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.707 |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 0.707 |
TP53BP1-Ser320 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | -1.367 |
ccRCC | |
GBM | |
HNSC | |
LUAD | 0.823 |
LUSC | -0.12 |
non_ccRCC | |
PDAC | |
UCEC | 0.664 |
TP53BP1-Ser321 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.049 |
HGSC | -1.635 |
ccRCC | |
GBM | |
HNSC | |
LUAD | 1.072 |
LUSC | 0.111 |
non_ccRCC | |
PDAC | |
UCEC | 0.404 |
TP53BP1-Ser328 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.516 |
HGSC | -1.499 |
ccRCC | |
GBM | |
HNSC | |
LUAD | 0.462 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 0.521 |
TP53BP1-Ser338 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -0.707 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 0.707 |
TP53BP1-Ser354 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | -0.707 |
non_ccRCC | |
PDAC | |
UCEC | 0.707 |
TP53BP1-Ser364 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.056 |
HGSC | -1.97 |
ccRCC | 0.135 |
GBM | |
HNSC | 0.748 |
LUAD | 0.568 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 0.463 |
TP53BP1-Ser365 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.194 |
HGSC | -2.17 |
ccRCC | 0.331 |
GBM | 0.514 |
HNSC | 0.459 |
LUAD | -0.134 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 0.807 |
TP53BP1-Ser371 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.363 |
HGSC | -2.39 |
ccRCC | 0.224 |
GBM | 0.432 |
HNSC | 0.282 |
LUAD | 0.45 |
LUSC | 0.787 |
non_ccRCC | -1.185 |
PDAC | 0.322 |
UCEC | 0.716 |
TP53BP1-Ser384 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.738 |
HGSC | -1.53 |
ccRCC | 0.308 |
GBM | 0.046 |
HNSC | 1.09 |
LUAD | -0.451 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 1.275 |
TP53BP1-Ser385 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.386 |
HGSC | -0.687 |
ccRCC | -1.022 |
GBM | 0.177 |
HNSC | 1.595 |
LUAD | |
LUSC | |
non_ccRCC | -1.225 |
PDAC | 0.946 |
UCEC | 0.602 |
TP53BP1-Ser400 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | 0.404 |
LUAD | -1.139 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 0.735 |
TP53BP1-Ser403 | |
---|---|
Cancer | Intensity |
BRCA | -0.985 |
COAD | -0.068 |
HGSC | 1.876 |
ccRCC | -0.131 |
GBM | -0.285 |
HNSC | 0.06 |
LUAD | -1.371 |
LUSC | -0.905 |
non_ccRCC | 1.623 |
PDAC | 0.257 |
UCEC | -0.07 |
TP53BP1-Ser498 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | -0.707 |
GBM | |
HNSC | |
LUAD | 0.707 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser505 | |
---|---|
Cancer | Intensity |
BRCA | -0.037 |
COAD | 0.014 |
HGSC | -2.9 |
ccRCC | 0.331 |
GBM | 0.067 |
HNSC | 0.367 |
LUAD | 0.392 |
LUSC | 0.005 |
non_ccRCC | 0.902 |
PDAC | 0.485 |
UCEC | 0.375 |
TP53BP1-Ser512 | |
---|---|
Cancer | Intensity |
BRCA | 1.485 |
COAD | 0.489 |
HGSC | -0.63 |
ccRCC | 0.023 |
GBM | 0.487 |
HNSC | 1.573 |
LUAD | 0.259 |
LUSC | -0.106 |
non_ccRCC | -1.184 |
PDAC | -0.978 |
UCEC | -1.417 |
TP53BP1-Ser517 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -0.707 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 0.707 |
TP53BP1-Ser523 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | -0.69 |
ccRCC | 0.759 |
GBM | |
HNSC | 0.019 |
LUAD | -1.257 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 1.17 |
TP53BP1-Ser525 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.506 |
HGSC | 0.654 |
ccRCC | 0.077 |
GBM | -2.217 |
HNSC | 0.145 |
LUAD | 0.301 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 0.535 |
TP53BP1-Ser528 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.171 |
HGSC | -1.639 |
ccRCC | -0.136 |
GBM | 0.779 |
HNSC | -0.185 |
LUAD | -0.644 |
LUSC | 2.069 |
non_ccRCC | 0.763 |
PDAC | -0.411 |
UCEC | -0.425 |
TP53BP1-Ser530 | |
---|---|
Cancer | Intensity |
BRCA | -0.036 |
COAD | 0.178 |
HGSC | -1.733 |
ccRCC | 0.596 |
GBM | 0.017 |
HNSC | 0.345 |
LUAD | -1.451 |
LUSC | -0.164 |
non_ccRCC | 2.072 |
PDAC | 0.245 |
UCEC | -0.069 |
TP53BP1-Ser535 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | 1.018 |
ccRCC | |
GBM | -0.981 |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | -0.037 |
TP53BP1-Ser537 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | 0.707 |
ccRCC | |
GBM | -0.707 |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser557 | |
---|---|
Cancer | Intensity |
BRCA | 0.648 |
COAD | -0.154 |
HGSC | -2.781 |
ccRCC | 0.241 |
GBM | -0.252 |
HNSC | 0.948 |
LUAD | -0.18 |
LUSC | 0.094 |
non_ccRCC | 0.681 |
PDAC | 0.458 |
UCEC | 0.296 |
TP53BP1-Ser571 | |
---|---|
Cancer | Intensity |
BRCA | -0.576 |
COAD | 1.754 |
HGSC | -0.006 |
ccRCC | -0.236 |
GBM | -1.184 |
HNSC | 0.071 |
LUAD | -0.992 |
LUSC | -0.507 |
non_ccRCC | 0.32 |
PDAC | 1.875 |
UCEC | -0.519 |
TP53BP1-Ser585 | |
---|---|
Cancer | Intensity |
BRCA | 0.535 |
COAD | -1.562 |
HGSC | -1.703 |
ccRCC | 0.742 |
GBM | -0.353 |
HNSC | -0.287 |
LUAD | -0.472 |
LUSC | 0.187 |
non_ccRCC | 1.433 |
PDAC | 1.064 |
UCEC | 0.415 |
TP53BP1-Ser603 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | 1.323 |
ccRCC | -0.58 |
GBM | -0.26 |
HNSC | |
LUAD | |
LUSC | -1.028 |
non_ccRCC | -0.475 |
PDAC | 1.521 |
UCEC | -0.501 |
TP53BP1-Ser635 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | -1.368 |
ccRCC | -0.486 |
GBM | 1.411 |
HNSC | 0.686 |
LUAD | |
LUSC | |
non_ccRCC | 0.327 |
PDAC | |
UCEC | -0.57 |
TP53BP1-Ser640 | |
---|---|
Cancer | Intensity |
BRCA | -0.305 |
COAD | |
HGSC | -1.283 |
ccRCC | |
GBM | |
HNSC | |
LUAD | 0.827 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 0.76 |
TP53BP1-Ser644 | |
---|---|
Cancer | Intensity |
BRCA | -1.334 |
COAD | 0.02 |
HGSC | -1.641 |
ccRCC | -0.056 |
GBM | 0.081 |
HNSC | 0.04 |
LUAD | 0.851 |
LUSC | |
non_ccRCC | |
PDAC | 1.617 |
UCEC | 0.421 |
TP53BP1-Ser645 | |
---|---|
Cancer | Intensity |
BRCA | -1.351 |
COAD | 0.124 |
HGSC | -1.73 |
ccRCC | -0.073 |
GBM | 0.456 |
HNSC | 0.134 |
LUAD | 0.53 |
LUSC | |
non_ccRCC | |
PDAC | 1.6 |
UCEC | 0.31 |
TP53BP1-Ser664 | |
---|---|
Cancer | Intensity |
BRCA | -1.928 |
COAD | |
HGSC | |
ccRCC | 0.231 |
GBM | -1.015 |
HNSC | 0.184 |
LUAD | 0.689 |
LUSC | |
non_ccRCC | 0.698 |
PDAC | 0.045 |
UCEC | 1.095 |
TP53BP1-Ser665 | |
---|---|
Cancer | Intensity |
BRCA | -1.928 |
COAD | |
HGSC | |
ccRCC | 0.231 |
GBM | -1.015 |
HNSC | 0.184 |
LUAD | 0.689 |
LUSC | |
non_ccRCC | 0.698 |
PDAC | 0.045 |
UCEC | 1.095 |
TP53BP1-Ser667 | |
---|---|
Cancer | Intensity |
BRCA | -1.933 |
COAD | |
HGSC | |
ccRCC | 0.323 |
GBM | -1.024 |
HNSC | 0.17 |
LUAD | 0.673 |
LUSC | |
non_ccRCC | 0.682 |
PDAC | 0.032 |
UCEC | 1.078 |
TP53BP1-Ser679 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.707 |
HNSC | -0.707 |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser68 | |
---|---|
Cancer | Intensity |
BRCA | 0.987 |
COAD | -2.012 |
HGSC | -1.715 |
ccRCC | 0.437 |
GBM | 0.453 |
HNSC | -0.118 |
LUAD | -0.346 |
LUSC | 0.676 |
non_ccRCC | 0.387 |
PDAC | 0.38 |
UCEC | 0.871 |
TP53BP1-Ser697 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | -0.055 |
LUAD | -1.182 |
LUSC | 1.264 |
non_ccRCC | -0.027 |
PDAC | |
UCEC |
TP53BP1-Ser718 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | 0.707 |
GBM | |
HNSC | -0.707 |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser726 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | -0.447 |
GBM | 1.442 |
HNSC | 0.504 |
LUAD | -0.336 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | -1.163 |
TP53BP1-Ser729 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.13 |
HGSC | -2.257 |
ccRCC | 0.179 |
GBM | -0.219 |
HNSC | 0.587 |
LUAD | 0.141 |
LUSC | 0.884 |
non_ccRCC | |
PDAC | |
UCEC | 0.814 |
TP53BP1-Ser732 | |
---|---|
Cancer | Intensity |
BRCA | -0.208 |
COAD | 0.142 |
HGSC | -2.711 |
ccRCC | 0.191 |
GBM | -0.037 |
HNSC | 0.05 |
LUAD | 0.206 |
LUSC | 0.05 |
non_ccRCC | 0.327 |
PDAC | 1.45 |
UCEC | 0.541 |
TP53BP1-Ser770 | |
---|---|
Cancer | Intensity |
BRCA | 0.423 |
COAD | |
HGSC | |
ccRCC | -0.747 |
GBM | |
HNSC | |
LUAD | -0.37 |
LUSC | |
non_ccRCC | -0.983 |
PDAC | 1.775 |
UCEC | -0.098 |
TP53BP1-Ser776 | |
---|---|
Cancer | Intensity |
BRCA | 0.271 |
COAD | 0.765 |
HGSC | -2.79 |
ccRCC | 0.158 |
GBM | -0.191 |
HNSC | -0.218 |
LUAD | 0.138 |
LUSC | -0.044 |
non_ccRCC | 0.472 |
PDAC | 1.01 |
UCEC | 0.428 |
TP53BP1-Ser787 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.707 |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 0.707 |
TP53BP1-Ser789 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.416 |
HGSC | -0.725 |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 1.141 |
TP53BP1-Ser791 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.396 |
HGSC | -0.758 |
ccRCC | -0.504 |
GBM | -0.548 |
HNSC | |
LUAD | -0.418 |
LUSC | |
non_ccRCC | 0.571 |
PDAC | |
UCEC | 2.053 |
TP53BP1-Ser814 | |
---|---|
Cancer | Intensity |
BRCA | 1.193 |
COAD | 0.263 |
HGSC | -1.342 |
ccRCC | 0.174 |
GBM | 0.512 |
HNSC | -0.612 |
LUAD | 0.029 |
LUSC | -1.749 |
non_ccRCC | 1.038 |
PDAC | 1.19 |
UCEC | -0.696 |
TP53BP1-Ser83 | |
---|---|
Cancer | Intensity |
BRCA | -1.09 |
COAD | |
HGSC | 0.998 |
ccRCC | |
GBM | 0.683 |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | -0.591 |
TP53BP1-Ser835 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.165 |
HGSC | -2.217 |
ccRCC | 0.396 |
GBM | 0.155 |
HNSC | 0.71 |
LUAD | 0.221 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 0.57 |
TP53BP1-Ser836 | |
---|---|
Cancer | Intensity |
BRCA | -0.736 |
COAD | 0.068 |
HGSC | -2.686 |
ccRCC | 0.772 |
GBM | 0.974 |
HNSC | 0.564 |
LUAD | 0.065 |
LUSC | 0.48 |
non_ccRCC | 0.333 |
PDAC | -0.008 |
UCEC | 0.173 |
TP53BP1-Ser839 | |
---|---|
Cancer | Intensity |
BRCA | -0.583 |
COAD | -0.188 |
HGSC | -2.68 |
ccRCC | 1.035 |
GBM | 0.581 |
HNSC | 0.651 |
LUAD | 0.173 |
LUSC | 0.34 |
non_ccRCC | 0.331 |
PDAC | -0.215 |
UCEC | 0.556 |
TP53BP1-Ser865 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | -0.191 |
GBM | 0.78 |
HNSC | 0.126 |
LUAD | -1.599 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 0.885 |
TP53BP1-Ser867 | |
---|---|
Cancer | Intensity |
BRCA | -0.274 |
COAD | -0.662 |
HGSC | -2.153 |
ccRCC | 0.879 |
GBM | 1.09 |
HNSC | 0.043 |
LUAD | -0.521 |
LUSC | -0.128 |
non_ccRCC | |
PDAC | 0.631 |
UCEC | 1.096 |
TP53BP1-Ser872 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.707 |
HGSC | -0.707 |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Ser980 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.791 |
HNSC | -1.124 |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 0.333 |
TP53BP1-Thr1060 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | 1.029 |
HNSC | -0.968 |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | -0.062 |
TP53BP1-Thr1061 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.269 |
HGSC | -0.937 |
ccRCC | |
GBM | 1.254 |
HNSC | -0.884 |
LUAD | 0.836 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Thr1127 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.707 |
HGSC | 0.707 |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
TP53BP1-Thr1297 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.984 |
HGSC | |
ccRCC | |
GBM | 1.016 |
HNSC | -0.032 |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |